https://www.guidedinc.com/guided-therapeutics-receives-new-half-million-dollar-purchase-order-from-china/2021-12-20T14:37:23-05:00https://www.guidedinc.com/guided-therapeutics-makes-final-payment-to-gpb-capital-holdings-for-secured-notes/2021-12-20T14:38:22-05:00https://www.guidedinc.com/guided-therapeutics-raises-us-1-1-million-in-new-preferred-stock-offering/2021-12-19T14:04:18-05:00https://www.guidedinc.com/guided-therapeutics-closes-2-114-million-series-f-preferred-stock-financing/2021-12-19T14:04:53-05:00https://www.guidedinc.com/guided-therapeutics-replaces-convertible-note-facility-and-significantly-reduces-dilution/2021-12-19T13:37:44-05:00https://www.guidedinc.com/guided-therapeutics-receives-news-from-chinese-state-food-and-drug-administration-that-luviva-meets-product-technical-requirements/2021-12-20T14:34:29-05:00https://www.guidedinc.com/new-european-published-study-shows-luviva-detects-20-more-precancerous-and-cancerous-cervical-disease-than-hpv-test/2021-12-20T14:32:22-05:00https://www.guidedinc.com/guided-therapeutics-receives-notification-of-successful-clinical-trial-regulatory-review-and-133000-payment-from-china/2021-12-20T14:31:25-05:00https://www.guidedinc.com/guided-therapeutics-ships-luviva-devices-to-china-for-start-of-clinical-trial-receives-additional-100000-payment/2021-12-20T14:30:00-05:00https://www.guidedinc.com/guided-therapeutics-announces-start-of-chinese-clinical-trial-for-approval-to-market-and-sell-luviva-in-china/2021-12-20T14:28:34-05:00https://www.guidedinc.com/guided-therapeutics-and-chinese-partner-shandong-yaohua-medical-instrument-corporation-complete-key-step-in-chinese-fda-approval-process/2021-12-19T14:10:36-05:00https://www.guidedinc.com/guided-therapeutics-announces-completion-of-a-1-5-million-financing-to-accelerate-2020-business-plan/2021-12-19T14:14:07-05:00https://www.guidedinc.com/guided-therapeutics-luviva-advanced-cervical-scan-awarded-new-ce-mark-with-expanded-claims/2021-12-19T14:17:53-05:00https://www.guidedinc.com/guided-therapeutics-successfully-uplists-to-over-the-counter-venture-market-from-pink-sheets/2021-12-19T14:21:17-05:00https://www.guidedinc.com/guided-therapeutics-submits-clinical-study-protocol-to-u-s-fda-for-luviva-advanced-cervical-scan/2021-12-19T14:23:25-05:00https://www.guidedinc.com/guided-therapeutics-continues-fda-progress-and-schedules-key-meeting-to-finalize-clinical-study-protocol-for-the-luviva-advanced-cervical-scan/2021-12-19T14:26:13-05:00https://www.guidedinc.com/guided-therapeutics-ships-luviva-devices-and-disposables-for-chinese-fda-pivotal-clinical-trial/2021-12-19T14:29:19-05:00https://www.guidedinc.com/after-meeting-with-fda-guided-therapeutics-to-start-study-in-support-of-its-application-for-fda-approval/2021-12-19T14:31:21-05:00https://www.guidedinc.com/company-profile-for-guided-therapeutics-inc/2021-12-20T04:32:02-05:00https://www.guidedinc.com/guided-therapeutics-announces-sales-and-training-center-in-budapest/2021-12-19T23:25:07-05:00https://www.guidedinc.com/guided-therapeutics-raises-funds-aimed-at-increasing-international-sales-and-restarting-us-fda-approval-process/2021-12-19T23:33:32-05:00https://www.guidedinc.com/guided-therapeutics-plans-growth-for-2020-after-closing-significant-financing/2021-12-19T23:41:19-05:00https://www.guidedinc.com/guided-therapeutics-files-pre-submission-document-with-u-s-fda-detailing-clinical-plan-to-support-approval/2021-12-19T23:48:25-05:00https://www.guidedinc.com/guided-therapeutics-and-fda-meet-agree-on-path-forward-in-approval-process/2021-12-19T23:54:06-05:00https://www.guidedinc.com/guided-therapeutics-reports-significant-progress-in-eliminating-variable-rate-convertible-loans-and-restructuring-capitalization-announces-reverse-stock-split/2021-12-20T00:01:07-05:00https://www.guidedinc.com/guided-therapeutics-receives-2-5-million-purchase-order-from-chinese-partner-shandong-medical-device-technology-company/2021-12-20T00:09:01-05:00https://www.guidedinc.com/guided-therapeutics-reports-new-progress-with-chinese-fda-and-increased-sales-forecast-from-shandong-medical-device-technology-company/2021-12-20T00:15:50-05:00https://www.guidedinc.com/guided-therapeutics-ships-8-luviva-devices-and-4500-single-use-cervical-guides-to-indonesia-in-q4-2017/2021-12-20T00:23:54-05:00https://www.guidedinc.com/guided-therapeutics-achieves-regulatory-approval-for-sale-in-india/2021-12-20T00:26:03-05:00https://www.guidedinc.com/346-2/2021-12-20T00:30:23-05:00https://www.guidedinc.com/dr-gene-cartwright-ceo-of-guided-therapeutics-joins-everett-jolly-on-uptick-newswires-stock-day-podcast-to-discuss-luviva-advanced-cervical-scan/2021-12-20T00:38:21-05:00https://www.guidedinc.com/new-data-released-at-european-conference-demonstrates-luviva-advanced-cervical-scan-detects-cervical-cancer-earlier-than-pap-and-hpv-tests/2021-12-20T00:45:59-05:00https://www.guidedinc.com/guided-therapeutics-provides-progress-update-on-international-activities/2021-12-20T00:50:52-05:00https://www.guidedinc.com/guided-therapeutics-announces-new-agreement-to-promote-sales-and-marketing-in-russia-and-eastern-europe/2021-12-20T00:54:07-05:00https://www.guidedinc.com/indonesia-places-new-orders-for-high-margin-luviva-advanced-cervical-scan-single-use-cervical-guides/2021-12-20T00:57:38-05:00https://www.guidedinc.com/guided-therapeutics-announces-extension-of-distribution-agreement-for-eastern-europe-and-russia/2021-12-20T01:00:51-05:00https://www.guidedinc.com/chinese-distributor-manufacturer-completes-1-million-payment-to-guided-therapeutics-and-orders-parts-in-anticipation-of-launch-next-year/2021-12-20T01:03:17-05:00https://www.guidedinc.com/indonesia-places-significant-order-for-new-luviva-devices-and-single-use-cervical-guides/2021-12-20T01:06:07-05:00https://www.guidedinc.com/guided-therapeutics-reports-significant-reductions-in-debt-and-operating-expenses/2021-12-20T01:08:57-05:00https://www.guidedinc.com/central-eastern-european-russian-distributor-expands-luviva-program-by-signing-manufacturing-supply-and-royalty-agreement-projects-purchases-of-30-million-over-5-years/2021-12-20T01:11:58-05:00https://www.guidedinc.com/guided-therapeutics-enters-into-luviva-advanced-cervical-scan-manufacturing-and-license-agreement-for-china/2021-12-20T01:24:26-05:00https://www.guidedinc.com/guided-therapeutics-ships-five-luviva-advanced-cervical-scans-to-chinese-partner-shandong-yaohua/2021-12-20T01:38:28-05:00https://www.guidedinc.com/guided-therapeutics-receives-order-for-10-luviva-advanced-cervical-scans-for-indonesia/2021-12-20T01:41:54-05:00https://www.guidedinc.com/guided-therapeutics-re-establishes-communications-with-u-s-fda-and-discusses-plan-for-refiling-for-approval-of-the-luviva-advanced-cervical-scan/2021-12-20T01:45:33-05:00https://www.guidedinc.com/guided-therapeutics-continues-to-grow-international-sales-with-new-order-of-disposables-from-indonesia-and-letter-of-intent-for-distribution-in-india/2021-12-20T01:49:43-05:00https://www.guidedinc.com/guided-therapeutics-signs-preliminary-license-agreement-with-turkish-distribution-partner-based-on-ministry-of-health-support-for-the-luviva-advanced-cervical-scan/2021-12-20T01:52:43-05:00https://www.guidedinc.com/guided-therapeutics-achieves-record-quarterly-revenue/2021-12-20T03:08:30-05:00https://www.guidedinc.com/guided-therapeutics-expects-significant-sales-growth-in-2016/2021-12-20T03:12:03-05:00https://www.guidedinc.com/guided-therapeutics-to-sell-five-additional-luviva-advanced-cervical-scans-to-nairobi-county-kenya-for-cervical-cancer-screening-program/2021-12-20T03:15:09-05:00https://www.guidedinc.com/guided-therapeutics-expands-luviva-advanced-cervical-scan-distribution-in-latin-america/2021-12-20T03:21:22-05:00https://www.guidedinc.com/guided-therapeutics-announces-1100-reverse-stock-split/2021-12-20T03:25:46-05:00https://www.guidedinc.com/guided-therapeutics-targeting-large-cervical-cancer-screening-markets-with-luviva-advanced-cervical-scan-with-new-single-patient-use-disposable/2021-12-20T03:29:29-05:00https://www.guidedinc.com/guided-therapeutics-schedules-conference-call-to-discuss-fourth-quarter-2015-financial-results/2021-12-20T03:43:41-05:00https://www.guidedinc.com/guided-therapeutics-luviva-advanced-cervical-scan-gaining-traction-in-the-middle-east/2021-12-20T03:46:07-05:00https://www.guidedinc.com/guided-therapeutics-reports-2015-results-with-strong-uptick-in-fourth-quarter/2021-12-20T03:50:21-05:00https://www.guidedinc.com/guided-therapeutics-shipping-largest-order-to-date-of-luviva-advanced-cervical-scan-single-patient-use-disposables/2021-12-20T03:52:52-05:00https://www.guidedinc.com/guided-therapeutics-issues-letter-to-shareholders/2021-12-20T03:56:41-05:00https://www.guidedinc.com/guided-therapeutics-ships-first-luviva-advanced-cervical-scan-for-the-dominican-republic/2021-12-20T03:59:41-05:00https://www.guidedinc.com/guided-therapeutics-reports-record-first-quarter-2016-results/2021-12-20T04:02:26-05:00https://www.guidedinc.com/guided-therapeutics-enters-into-luviva-advanced-cervical-scan-license-agreement-for-china/2021-12-20T04:06:12-05:00https://www.guidedinc.com/guided-therapeutics-expanding-use-of-the-luviva-advanced-cervical-scan-in-bulgaria/2021-12-20T04:07:50-05:00https://www.guidedinc.com/guided-therapeutics-ships-five-luviva-advanced-cervical-scans-to-nairobi-county-kenya-for-cervical-cancer-screening-program/2021-12-20T04:09:30-05:00https://www.guidedinc.com/guided-therapeutics-sells-first-luviva-advanced-cervical-scan-to-russia/2021-12-20T04:11:48-05:00https://www.guidedinc.com/guided-therapeutics-ships-additional-luviva-advanced-cervical-scan-systems-and-disposables-to-bangladesh/2021-12-20T04:13:54-05:00https://www.guidedinc.com/guided-therapeutics-reports-second-quarter-2016-financial-results-year-to-date-revenue-up-71-over-same-period-last-year/2021-12-20T04:15:24-05:00https://www.guidedinc.com/guided-therapeutics-receives-order-for-7-luviva-advanced-cervical-scans-and-4000-disposable-cervical-guides-for-indonesia/2021-12-20T04:17:43-05:00https://www.guidedinc.com/guided-therapeutics-announces-1800-reverse-stock-split-and-elimination-of-toxic-convertible-securities-from-its-balance-sheet/2021-12-20T04:19:05-05:00https://www.guidedinc.com/guided-therapeutics-provides-an-update-on-fda-review-time-for-luviva-advanced-cervical-scan/2021-12-20T07:01:08-05:00https://www.guidedinc.com/guided-therapeutics-to-report-fourth-quarter-2014-results-and-hold-conference-call-provide-update-on-business-activity/2021-12-20T07:04:11-05:00https://www.guidedinc.com/guided-therapeutics-reports-2014-results/2021-12-20T07:08:19-05:00https://www.guidedinc.com/guided-therapeutics-ships-first-commercial-luviva-advanced-cervical-scans-to-indonesia/2021-12-20T07:10:02-05:00https://www.guidedinc.com/guided-therapeutics-completes-interim-financing-initiating-distribution-of-luviva-advanced-cervical-scan-in-china/2021-12-20T07:11:36-05:00https://www.guidedinc.com/canadian-pilot-programs-initiated-with-luviva-advanced-cervical-scan-for-provincial-level-cancer-care-support/2021-12-20T07:27:01-05:00https://www.guidedinc.com/guided-therapeutics-to-report-first-quarter-2015-results-and-hold-conference-call-provide-update-on-luviva-fda-timing/2021-12-20T07:29:38-05:00https://www.guidedinc.com/county-government-of-nairobi-kenya-purchases-initial-luviva-advanced-cervical-scan-for-cervical-cancer-screening-program/2021-12-20T07:37:30-05:00https://www.guidedinc.com/guided-therapeutics-reports-first-quarter-2015-results/2021-12-20T07:43:50-05:00https://www.guidedinc.com/fda-completes-review-of-guided-therapeutics-luviva-advanced-cervical-scan-pma-application/2021-12-20T07:47:16-05:00https://www.guidedinc.com/guided-therapeutics-awarded-multiple-tenders-for-luviva-advanced-cervical-scan-systems-from-governments-in-bangladesh/2021-12-20T07:48:49-05:00https://www.guidedinc.com/turkish-ministry-of-health-expanding-usage-of-guided-therapeutics-luviva-advanced-cervical-scan-driving-significant-new-orders/2021-12-20T07:50:07-05:00https://www.guidedinc.com/guided-therapeutics-announces-4-million-private-placement/2021-12-20T07:51:40-05:00https://www.guidedinc.com/guided-therapeutics-distributor-signs-new-four-year-deal-to-sell-10-million-of-luviva-advanced-cervical-scans-to-turkish-ministry-of-health/2021-12-20T07:53:21-05:00https://www.guidedinc.com/guided-therapeutics-schedules-conference-call-to-discuss-second-quarter-2015-financial-results/2021-12-20T07:54:32-05:00https://www.guidedinc.com/guided-therapeutics-reports-second-quarter-2015-financial-results-closes-10-million-deal/2021-12-20T07:55:53-05:00https://www.guidedinc.com/guided-therapeutics-advances-luviva-pma-application-with-fda/2021-12-20T07:56:58-05:00https://www.guidedinc.com/guided-therapeutics-submits-proposal-to-kenya-to-increase-cervical-cancer-screening-rates-potential-screening-population-of-12-million-women/2021-12-20T07:58:09-05:00https://www.guidedinc.com/guided-therapeutics-expands-access-of-the-luviva-advanced-cervical-scan-into-costa-rica/2021-12-20T07:59:16-05:00https://www.guidedinc.com/guided-therapeutics-expands-access-of-the-luviva-advanced-cervical-scan-into-bulgaria/2021-12-20T08:00:19-05:00https://www.guidedinc.com/guided-therapeutics-announces-550000-increase-to-4-million-private-placement-and-accelerated-interim-closing/2021-12-20T08:02:11-05:00https://www.guidedinc.com/guided-therapeutics-turkish-distributor-doubles-order-for-luviva-advanced-cervical-scan-single-use-disposables-for-turkish-ministry-of-health/2021-12-20T08:03:15-05:00https://www.guidedinc.com/guided-therapeutics-and-u-s-fda-agree-on-meeting-date-to-plan-path-forward-for-luviva-advanced-cervical-scan-premarket-approval-application/2021-12-20T08:04:25-05:00https://www.guidedinc.com/guided-therapeutics-to-present-at-2015-aegis-growth-conference/2021-12-20T08:08:14-05:00https://www.guidedinc.com/guided-therapeutics-ships-first-four-luviva-advanced-cervical-scans-for-14-million-turkish-ministry-of-health-order/2021-12-20T08:09:41-05:00https://www.guidedinc.com/study-finds-guided-therapeutics-luviva-advanced-cervical-scan-can-predict-future-worsening-of-precancer/2021-12-20T08:11:04-05:00https://www.guidedinc.com/guided-therapeutics-fourth-quarter-orders-of-luviva-advanced-cervical-scan-disposables-triple-2014-total-sales/2021-12-20T08:12:14-05:00https://www.guidedinc.com/guided-therapeutics-expands-china-rights-negotiations-for-luviva-advanced-cervical-scan-to-three-potential-partners/2021-12-20T08:14:02-05:00https://www.guidedinc.com/2016-turkish-ministry-of-health-order-for-guided-therapeutics-luviva-advanced-cervical-scan-four-times-2015-projected-revenue/2021-12-20T08:15:11-05:00https://www.guidedinc.com/fda-grants-guided-therapeutics-request-for-new-meeting-date-to-plan-path-forward-for-luviva-advanced-cervical-scan-pma-application/2021-12-20T08:16:37-05:00https://www.guidedinc.com/guided-therapeutics-schedules-conference-call-to-discuss-third-quarter-2015-financial-results/2021-12-20T08:17:43-05:00https://www.guidedinc.com/new-nigerian-minister-of-health-is-early-supporter-of-guided-therapeutics-luviva-advanced-cervical-scan-use-in-africa/2021-12-20T08:18:48-05:00https://www.guidedinc.com/guided-therapeutics-reports-third-quarter-2015-financial-results/2021-12-20T08:20:09-05:00https://www.guidedinc.com/guided-therapeutics-to-present-at-ld-micro-main-event-investor-conference/2021-12-20T08:21:11-05:00https://www.guidedinc.com/guided-therapeutics-and-fda-review-team-agree-on-path-forward-for-luviva-advanced-cervical-scan-pma-application/2021-12-20T08:22:13-05:00https://www.guidedinc.com/guided-therapeutics-ships-first-order-of-10000-luviva-advanced-cervical-scan-disposables-for-14-million-turkish-ministry-of-health-order/2021-12-20T08:23:22-05:00https://www.guidedinc.com/guided-therapeutics-names-gene-cartwright-as-chief-executive-officer/2021-12-20T10:36:00-05:00https://www.guidedinc.com/guided-therapeutics-to-report-fourth-quarter-2013-results-and-hold-conference-call/2021-12-20T10:45:16-05:00https://www.guidedinc.com/new-clinical-study-results-of-guided-therapeutics-luviva-advanced-cervical-scan-to-be-presented-by-key-opinion-leaders-at-top-international-medical-conference/2021-12-20T10:45:06-05:00https://www.guidedinc.com/guided-therapeutics-submits-request-for-face-to-face-meeting-with-fda-receives-notification-on-pma-extension-for-luviva-advanced-cervical-scan/2021-12-20T10:49:46-05:00https://www.guidedinc.com/hpv-screening-beneficial-for-guided-therapeutics-luviva-advanced-cervical-scan-in-developed-countries-no-anticipated-impact-in-developing-countries/2021-12-20T10:46:59-05:00https://www.guidedinc.com/guided-therapeutics-reports-fourth-quarter-and-2013-results/2021-12-20T10:48:37-05:00https://www.guidedinc.com/guided-therapeutics-luviva-honored-as-finalist-in-the-medical-device-excellence-awards/2021-12-20T10:53:19-05:00https://www.guidedinc.com/guided-therapeutics-receives-may-8th-meeting-date-from-fda-to-discuss-luviva-advanced-cervical-scan-pma-application/2021-12-20T10:54:44-05:00https://www.guidedinc.com/guided-therapeutics-announces-private-placement-of-up-to-3000000-in-senior-convertible-notes/2021-12-20T10:56:08-05:00https://www.guidedinc.com/guided-therapeutics-set-to-file-amended-pma-application-for-luviva-advanced-cervical-scan-after-productive-face-to-face-meeting-with-fda/2021-12-20T10:58:50-05:00https://www.guidedinc.com/guided-therapeutics-to-report-first-quarter-2014-results-and-hold-conference-call/2021-12-20T10:57:39-05:00https://www.guidedinc.com/guided-therapeutics-reports-first-quarter-2014-results/2021-12-20T11:01:46-05:00https://www.guidedinc.com/guided-therapeutics-announces-completion-of-private-placement-of-senior-convertible-notes/2021-12-20T11:35:30-05:00https://www.guidedinc.com/guided-therapeutics-luviva-advanced-cervical-scan-detected-100-of-precancers-in-new-blinded-clinical-study-presented-at-an-international-cervical-pathology-and-colposcopy-conference/2021-12-20T11:42:05-05:00https://www.guidedinc.com/guided-therapeutics-to-present-at-annual-marcum-microcap-conference-on-thursday-may-29/2021-12-20T11:45:45-05:00https://www.guidedinc.com/guided-therapeutics-to-present-at-ld-micro-invitational-conference-on-wednesday-june-4/2021-12-20T11:48:37-05:00https://www.guidedinc.com/guided-therapeutics-luviva-advanced-cervical-scan-wins-prestigious-medical-design-award/2021-12-20T11:50:46-05:00https://www.guidedinc.com/guided-therapeutics-second-quarter-sales-to-reach-200000-update-timing-for-amended-pma-application-for-luviva-advanced-cervical-scan/2021-12-20T11:54:14-05:00https://www.guidedinc.com/guided-therapeutics-luviva-advanced-cervical-scan-awarded-mexican-regulatory-approval/2021-12-20T11:57:30-05:00https://www.guidedinc.com/guided-therapeutics-granted-additional-key-patent-for-luviva-advanced-cervical-scan/2021-12-20T12:21:55-05:00https://www.guidedinc.com/guided-therapeutics-files-pma-amendment-with-fda-for-luviva-advanced-cervical-scan/2021-12-20T12:26:15-05:00https://www.guidedinc.com/guided-therapeutics-to-report-second-quarter-2014-results-and-hold-conference-call/2021-12-20T12:29:14-05:00https://www.guidedinc.com/guided-therapeutics-reports-second-quarter-2014-results/2021-12-20T12:38:10-05:00https://www.guidedinc.com/guided-therapeutics-initiates-cervical-cancer-screening-trial-for-luviva-advanced-cervical-scan/2021-12-20T12:41:37-05:00https://www.guidedinc.com/guided-therapeutics-to-present-at-rodman-renshaw-16th-annual-global-investment-conference-on-wednesday-september-10th/2021-12-20T12:44:37-05:00https://www.guidedinc.com/guided-therapeutics-announces-initial-200000-investment-from-turkish-distributor-item-medical-technologies-group/2021-12-20T13:31:28-05:00https://www.guidedinc.com/guided-therapeutics-to-report-third-quarter-2014-results-and-hold-conference-call/2021-12-20T13:33:10-05:00https://www.guidedinc.com/guided-therapeutics-reports-third-quarter-2014-results/2021-12-20T13:34:22-05:00https://www.guidedinc.com/nigerian-clinical-studies-demonstrate-advantages-of-luviva-advanced-cervical-scan-for-screening-and-detecting-cervical-pre-cancer-in-africa/2021-12-20T13:35:49-05:00https://www.guidedinc.com/guided-therapeutics-announces-pricing-of-3-8-million-public-offering/2021-12-20T13:37:01-05:00https://www.guidedinc.com/clinical-results-presented-at-turkish-medical-congress-further-support-luviva-advanced-cervical-scan-for-primary-screening-and-detection-of-cervical-cancer/2021-12-20T13:38:13-05:00https://www.guidedinc.com/guided-therapeutics-to-present-at-sidoti-company-llc-2013-micro-cap-conference-on-monday-january-7/2021-12-20T13:42:25-05:00https://www.guidedinc.com/guided-therapeutics-successfully-completes-canadian-standard-association-requirements-for-luviva-advanced-cervical-scan/2021-12-20T13:43:39-05:00https://www.guidedinc.com/guided-therapeutics-to-present-at-noble-financial-capital-markets-ninth-annual-equity-conference-on-tuesday-january-22/2021-12-20T13:44:49-05:00https://www.guidedinc.com/guided-therapeutics-to-showcase-luviva-advanced-cervical-scan-at-arab-health-2013/2021-12-20T13:46:25-05:00https://www.guidedinc.com/guided-therapeutics-to-develop-esophageal-cancer-product-acquires-intellectual-property-rights-from-konica-minolta/2021-12-20T13:47:49-05:00https://www.guidedinc.com/guided-therapeutics-passes-annual-iso-quality-audit-necessary-for-continued-ce-mark-certification/2021-12-20T13:49:12-05:00https://www.guidedinc.com/guided-therapeutics-receives-1-65-million-from-exercised-warrants/2021-12-20T13:50:16-05:00https://www.guidedinc.com/guided-therapeutics-to-report-fourth-quarter-and-year-end-2012-results-and-hold-conference-call/2021-12-20T13:51:27-05:00https://www.guidedinc.com/guided-therapeutics-ships-initial-edition-3-ce-marked-luviva-advanced-cervical-scan/2021-12-20T13:54:46-05:00https://www.guidedinc.com/guided-therapeutics-reports-year-end-and-fourth-quarter-2012-results/2021-12-20T13:53:05-05:00https://www.guidedinc.com/guided-therapeutics-luviva-advanced-cervical-scan-clinical-trial-results-to-be-published-in-journal-gynecologic-oncology/2021-12-20T13:56:00-05:00https://www.guidedinc.com/guided-therapeutics-inc-otcbb-gthp-otcqb-gthp-today-announced-its-operating-results-for-the-first-quarter-ended-march-31-2013-revenue-and-other-income-for-the-first-quarter-of-2013-was-appr/2021-12-20T14:07:14-05:00https://www.guidedinc.com/guided-therapeutics-to-report-first-quarter-2013-results-and-hold-conference-call/2021-12-20T13:57:12-05:00https://www.guidedinc.com/guided-therapeutics-reports-first-quarter-2013-results/2021-12-20T13:58:32-05:00https://www.guidedinc.com/guided-therapeutics-luviva-advanced-cervical-scan-cited-as-promising-solution-to-reduce-unnecessary-painful-and-costly-procedures-in-european-healthcare-settings/2021-12-20T14:01:28-05:00https://www.guidedinc.com/guided-therapeutics-and-i-t-e-m-medical-technologies-group-announce-turkish-ministry-of-health-sponsored-cervical-cancer-prevention-program-involving-the-luviva-advanced-cervical-scan/2021-12-20T14:03:00-05:00https://www.guidedinc.com/guided-therapeutics-to-report-second-quarter-2013-results-and-hold-conference-call/2021-12-20T14:06:20-05:00https://www.guidedinc.com/guided-therapeutics-continues-to-await-update-from-fda-on-its-pma-application-for-luviva-advanced-cervical-scan/2021-12-20T14:04:15-05:00https://www.guidedinc.com/guided-therapeutics-to-report-third-quarter-2013-results-and-hold-conference-call/2021-12-20T14:18:03-05:00https://www.guidedinc.com/guided-therapeutics-reports-second-quarter-2013-results/2021-12-20T14:10:23-05:00https://www.guidedinc.com/guided-therapeutics-receives-additional-questions-from-fda-for-luviva-advanced-cervical-scan/2021-12-20T14:12:36-05:00https://www.guidedinc.com/guided-therapeutics-secures-additional-distribution-for-luviva-advanced-cervical-scan/2021-12-20T14:14:13-05:00https://www.guidedinc.com/guided-therapeutics-announces-warrant-exchange-offer/2021-12-20T14:15:42-05:00https://www.guidedinc.com/guided-therapeutics-receives-250000-milestone-payment/2021-12-20T14:16:55-05:00https://www.guidedinc.com/guided-therapeutics-submits-pma-amendment-to-fda-for-luviva-advanced-cervical-scan/2021-12-20T14:22:30-05:00https://www.guidedinc.com/guided-therapeutics-reports-third-quarter-2013-results/2021-12-20T14:19:31-05:00https://www.guidedinc.com/guided-therapeutics-reports-third-quarter-2012-results/2021-12-20T14:24:12-05:00https://www.guidedinc.com/guided-therapeutics-successfully-completes-electrical-testing-of-luviva-advanced-cervical-scan-for-edition-3-ce-and-canadian-standards-association-marks/2021-12-20T14:25:30-05:00https://www.guidedinc.com/guided-therapeutics-announces-testing-completion-of-first-150-patients-in-chinese-clinical-study-and-receives-milestone-payment-of-177740/2022-03-31T11:11:46-04:00